AIM
NVO

Acrospire Investment Management’s Novo Nordisk NVO Stock Holding History

Acrospire Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,616
Closed -$35K – 959
2017
Q2 		$35K Buy
1,616
+1,000
+162% +$20.2K 0.03% 1177
2017
Q1 		$11K Buy
+616
New +$10.7K 0.01% 1846
2016
Q3 		– Sell
-1,800
Closed -$48K – 2100
2016
Q2 		$48K Buy
1,800
+1,000
+125% +$27.4K 0.04% 1086
2016
Q1 		$22K Buy
+800
New +$21.4K 0.02% 1496

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Acrospire Investment Management's NVO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Novo Nordisk (NVO) in Q3 2017, closing a stake of 1,616 shares — an estimated $35K sold.

Acrospire Investment Management first reported a position in NVO in Q1 2016 and held it in 4 quarters. The position peaked at $48K in Q2 2016. 491 funds tracked by Wall St. Rank hold NVO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Novo Nordisk position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,616 Novo Nordisk shares in Q3 2017, an estimated $35K.
  • Acrospire Investment Management first reported a position in Novo Nordisk in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Novo Nordisk position peaked at $48K in Q2 2016.
  • 491 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.